{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:59:32Z","timestamp":1788692372368,"version":"build-2803163510"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,4,1]]},"DOI":"10.2169\/internalmedicine.2211-23","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T22:12:17Z","timestamp":1691532737000},"page":"911-918","source":"Crossref","is-referenced-by-count":4,"title":["Similar Effect of Vonoprazan and Oral Proton Pump Inhibitors for Preventing Rebleeding in Cases of Upper Gastrointestinal Bleeding"],"prefix":"10.2169","volume":"63","author":[{"given":"Hiroko","family":"Abe","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[{"name":"Department of Health Administration and Policy, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waku","family":"Hatta","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Koike","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Ono","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ogata","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Jin","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanno","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Uno","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Asano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Imatani","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[{"name":"Department of Health Administration and Policy, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Laine L, Yang H, Chang SC, Datto C. Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009. Am J Gastroenterol 107: 1190-1195, 2012.","DOI":"10.1038\/ajg.2012.168"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci 63: 1286-1293, 2018.","DOI":"10.1007\/s10620-017-4882-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Abougergi MS, Travis AC, Saltzman JR. The in-hospital mortality rate for upper GI hemorrhage has decreased over 2 decades in the United States: a nationwide analysis. Gastrointest Endosc 81: 882-888, 2015.","DOI":"10.1016\/j.gie.2014.09.027"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Hearnshaw SA, Logan RF, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 60: 1327-1335, 2011.","DOI":"10.1136\/gut.2010.228437"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mullady DK, Wang AY, Waschke KA. AGA clinical practice update on endoscopic therapies for non-variceal upper gastrointestinal bleeding: expert review. Gastroenterology 159: 1120-1128, 2020.","DOI":"10.1053\/j.gastro.2020.05.095"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fujishiro M, Iguchi M, Kakushima N, et al. Guidelines for endoscopic management of non-variceal upper gastrointestinal bleeding. Dig Endosc 28: 363-378, 2016.","DOI":"10.1111\/den.12639"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Matsuhashi T, Fukuda S, Mikami T, et al. Effects of anti-thrombotic drugs on all-cause mortality after upper gastrointestinal bleeding in Japan: a multicenter study with 2205 cases. Dig Endosc 34: 113-122, 2022.","DOI":"10.1111\/den.13961"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kondo Y, Hatta W, Koike T, et al. The use of higher dose steroids increases the risk of rebleeding after endoscopic hemostasis for peptic ulcer bleeding. Dig Dis Sci 63: 3033-3040, 2018.","DOI":"10.1007\/s10620-018-5209-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chang A, Ouejiaraphant C, Akarapatima K, Rattanaspa A, Prachayakul V. Prospective comparison of the AIMS65 score, Glasgow-Blatchford score, and Rockall score for predicting clinical outcomes in patients with variceal and nonvariceal upper gastrointestinal bleeding. Clin Endosc 54: 211-221, 2021.","DOI":"10.5946\/ce.2020.068"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Matsuhashi T, Hatta W, Hikichi T, et al. A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleeding. J Gastroenterol 56: 758-768, 2021.","DOI":"10.1007\/s00535-021-01797-w"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chiu PW, Ng EK, Cheung FK, et al. Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol 7: 311-316, 2009.","DOI":"10.1016\/j.cgh.2008.08.044"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lau JY, Sung JJ, Lam YH, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 340: 751-756, 1999.","DOI":"10.1056\/NEJM199903113401002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Barkun AN, Almadi M, Kuipers EJ, et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. Ann Intern Med 171: 805-822, 2019.","DOI":"10.7326\/M19-1795"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zhang YS, Li Q, He BS, Liu R, Li ZJ. Proton pump inhibitors therapy <i>vs<\/i> H<sub>2<\/sub> receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: a meta-analysis. World J Gastroenterol 21: 6341-6351, 2015.","DOI":"10.3748\/wjg.v21.i20.6341"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study. Aliment Pharmacol Ther 42: 719-730, 2015.","DOI":"10.1111\/apt.13325"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for <i>Helicobacter pylori<\/i> eradication: a phase III, randomised, double-blind study. Gut 65: 1439-1446, 2016.","DOI":"10.1136\/gutjnl-2015-311304"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ashida K, Sakurai Y, Nishimura A, et al. Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Aliment Pharmacol Ther 42: 685-695, 2015.","DOI":"10.1111\/apt.13331"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Abe H, Hatta W, Ogata Y, et al. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J Gastroenterol 56: 640-650, 2021.","DOI":"10.1007\/s00535-021-01781-4"},{"key":"19","unstructured":"19. Br\u00e4mer GR. International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q 41: 32-36, 1988."},{"key":"20","unstructured":"20. Ministry of Health, Labour and Welfare. Various information of medical free [Internet]. [cited 2023 Mar 3]. Available from: https:\/\/shinryohoshu.mhlw.go.jp\/shinryohoshu\/"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 27: 476-482, 2017.","DOI":"10.1016\/j.je.2016.09.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383, 1987.","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34: 3661-3679, 2015.","DOI":"10.1002\/sim.6607"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Yang Z, Wu Q, Liu Z, Wu K, Fan D. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials. Digestion 84: 315-320, 2011.","DOI":"10.1159\/000331138"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hatta W, Tsuji Y, Yoshio T, et al. Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score. Gut 70: 476-484, 2021.","DOI":"10.1136\/gutjnl-2019-319926"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hashimoto M, Hatta W, Tsuji Y, et al. Rebleeding in patients with delayed bleeding after endoscopic submucosal dissection for early gastric cancer. Dig Endosc 33: 1120-1130, 2021.","DOI":"10.1111\/den.13943"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Elmunzer BJ, Young SD, Inadomi JM, Schoenfeld P, Laine L. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol 103: 2625-2632, 2008.","DOI":"10.1111\/j.1572-0241.2008.02070.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Garcia-Iglesias P, Villoria A, Suarez D, et al. Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer. Aliment Pharmacol Ther 34: 888-900, 2011.","DOI":"10.1111\/j.1365-2036.2011.04830.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/7\/63_2211-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T03:37:39Z","timestamp":1712374659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/7\/63_2211-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2211-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"article-number":"2211-23"}}